siRNA oligonucleotides
The following siRNA oligonucleotides were used for this study. The distribution of HIP1 expression was binormal and exhibited two clusters low and high expressers. Red lines fit the distribution of low expression of HIP1 and green lines high expression. The value of HIP1 expression is detected by q RT-PCR in ZJH cohort and RNA sequencing in TCGA cohort. In ZIH cohort, 90 (33%) were classified as low and 180 (67%) high HIP1 expression. In TCGA cohort, 66 (33%) were defined as low HIP1 expressers and 131 (67%) as high expressers. Each cutoff value was estimated using Cutoff Finder software analysis, respectively. Relative expression of HIP1 in the ZJH cohort is multiplied by 100. . Hazard ratios (HR) of altered HIP1 mRNA on overall survival by stratified analyses. "P value" represents the p-values after adjustment analyses for each factor, and "Pi value" represents the p-values of interaction between altered levels of HIP1 mRNA expression and each factor. The prognostic value of HIP1 expression is significant in univariate analysis (UV) for OS. The adjustment p-values do not strikingly change after adjustment for each factor, implying each adjusted factor does not significantly alter the interpretation of the prognostic value of HIP1 mRNA expression. The p-values of interaction (Pi value) between HIP1 mRNA expression and each factor are more than 0.05, indicating no apparent interactive factors exist. Figure S4 . Silencing HIP1 expression in Kasumi-1 and THP-1 cell lines, respectively. The cells were treated with 50 nM HIP1-siRNA, negative control siRNA, lipofectamine reagent without siRNA (blank control) and culture only. The relative expression of HIP1 was determined by Real-time PCR analysis after 72 hours transfection. The relative quantification of the HIP1 expression was determined using the 2 -ΔΔCt method and GAPDH was used for normalization. Expression levels were analyzed relative to the sample cultured only as 100%. Statistical analysis was performed using one-way ANOVA followed by Tukey post-test. There was significantly decreased expression of HIP1 in HIP-1-siRNA group compared to negative control. However, no significant changes were seen among negative control, blank control and culture only group. "***" represents P<0.001. The protocols used for induction therapy in different groups including donorubicin/Ara-C (DA)-based treatment group and idarubicin/Ara-C (IA)-based; CI, confidence intervals; HR, hazard ratio. 
